On November 4th, 2025, we announced that Parse Biosciences plans to join QIAGEN later this year.
We’re thrilled to be a part of such a well-respected organization, known for its innovative, high-quality tools for bioscience research.
To our first 3,000 customers, your inspirational research using our products, in addition to your valuable feedback, is what has driven us and will continue to drive us to deliver high-quality products for the whole community. It has been a privilege to work with you so far, and we look forward to continuing to support your efforts for years to come. We’re excited to now be able to offer our products to the 500,000 labs that the wider QIAGEN team serves, making single cell sequencing more scalable and more accessible than ever before.
As a QIAGEN company, Parse will also be accelerating innovation and product development faster than ever. Backed by a robust global infrastructure, you can expect more exciting innovations in single cell analysis and we look forward to sharing more news in the near future.
Rest assured:
At the core of all that we do is YOU, our customers. You are the reason we keep pushing forward, advancing what’s possible with single cell analysis. The work you do inspires us to keep driving, delivering exceptional products and solutions that help you achieve your largest research goals.
Thank you for joining us on this journey! We’re so excited to see what we’ll all achieve together.
Read more on QIAGEN’s website.
Reach out for help planning your next experiment.